SureTrader
Home > Boards > US OTC > Medical - Drugs >

Bioelectronics Corp. (BIEL)

BIEL RSS Feed
Add BIEL Price Alert      Hide Sticky   Hide Intro
Moderator: yankee55, stockdarockk, misanthrope, REDZONE, Det_Robert_Thorne, seven-up
Search This Board: 
Last Post: 2/19/2018 12:09:05 AM - Followers: 738 - Board type: Free - Posts Today: 1

FDA HAS CLEARED ACTIPATCH A

BIOELECTRONIC CORP PRODUCT FOR

OVER THE COUNTER SALES 2/3/2017.

BIEL IS THE STOCK SYMBOL 


http://www.accessdata.fda.gov/cdrh_docs/pdf15/K152432.pdf

Actipatch for Knee Pain

Actipatch Smart Insole for Heel Pain Relief




11/30/2017 - The US Solicitor General abandons support of the SEC Administrative Law Judge System, favorable implications for the SEC Administrative Proceeding with BIEL 

12/7/2017 - Try and Tell US Launch, gets a 7 Day ActiPatch to US residents for shipping and handling costs of $4.95 

12/7/17 - BIEL closes deal with ANDA for National Distribution, ANDA has 60,000 commercial customers and is owned by TEVA Pharma, TEVA has extensive business dealings with the NHS 

1/4/2018 - ActiPatch gains admission to the UK NHS Drug Tariff as a covered medical device, The NHS is the largest single healthcare delivery organization in the world 

1/9/2018 - CARE Pharmacies will be handling the ActiPatch, CARE is an organization of 90 pharmacies in 17 states, CARE will be educating patients on the benefits of drug free pain relief through Pain Consultations 

1/16/2018 - Allay Menstrual Clinical Study is fully enrolled, taking place at the prestigious Birmingham Women's Hospital, a NHS Foundation Hospital 

1/16/2018 - US Supreme Court agrees to Hear case that challenges the Constitutionality of SEC Judges, major implications for SEC AP action with BIEL 

1/22/2018 - BIEL signs deal with Performance Health, 120 outside sales reps, 40 inside reps, KN interview 

1/22/2018 - BIEL signs deal with MundiPharma in Australia and 8 other countries, Mundi is associated with Purdue Pharma, KN interview 

1/22/2018 - Back Pain Study is complete, BIEL has dialogue ongoing with FDA for submission of Study to expand ActiPatch indications, KN interview 

1/22/2018 - Migraine Study will get full attention of staff now that the Back Study has been completed 

1/22/2018 - BIEL in talks with Walmart 

1/22/2018 - Meeting scheduled with CVS 

This is the last 2 months of activity for BIEL. Any other OTC company would be dancing in the Street if they had accomplished this much in the last year. 

The NHS Approval has opened new doors for BIEL and will continue to do so for many years. 



 

BioElectronics ActiPatch Drug-Free Pain Therapy Receives United Kingdom National Health System Payment Coverage

 

 
 
 
 
 
January 04, 2018 07:00 ET Source: BioElectronics Corporation
 
 

FREDERICK, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com makes wearable, drug-free chronic pain therapy medical devices. It is pleased to announce that the UK’s government-funded public health service, National Health System (NHS), has approved our application to cover and pay for ActiPatch® Musculoskeletal Pain Therapy. The NHS estimates that almost half of the 50 million UK adults may be living with chronic-pain¹, which is why there are more than 100,000 physician visits every day for musculoskeletal pain alone².

The ActiPatch is a drug-free, wearable medical device that regulates peripheral nerve activity to provide pain relief. The NHS based its decision considering strong clinical evidence and a health economics study, which found that ActiPatch significantly decreased pain and improved quality of life, while reducing overall healthcare costs by 42% (58.5% reduction in physician appointment costs, 35% reduction in prescription medication costs).

“This is a major win for pain sufferers in the UK, since they will now be able to obtain a prescription for ActiPatch, the cost of which will be covered by the government,” stated Ian Rawe, Ph.D., Director of Clinical Research at BioElectronics. “We commend this move by the NHS, as this will open up the doors for reimbursement in the US and other managed care markets. This will likely have a tremendous impact on our sales and marketability of the product in the UK and elsewhere,” said Keith Nalepka, VP of Sales & Marketing at BioElectronics.

With the addition of ActiPatch to list of approved treatments, chronic pain sufferers now have access to paid safe, drug-free chronic pain relief. The ActiPatch will be listed for payment coverage in April.

About BioElectronics Corporation

BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: For more information, please visit www.bielcorp.com.

References

1 NHS, "NHS Choices," January 2018. [Online]. Available: https://www.nhs.uk/news/medical-practice/almost-half-of-all-uk-adults-may-be-living-with-chronic-pai....

2 Arthritis Research UK, "Muscloskeletal Matters," Keele University, 2009.

 

 Contact:  Paul Knopick  940.262.3584  pknopick@eandecommunications.com




February 06, 2017 09:05 ET

BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch® Musculoskeletal Pain Therapy

FREDERICK, MD--(Marketwired - Feb 6, 2017) -  BioElectronics Corporation (OTC PINK: BIEL), the maker of wearable pain therapy devices, announced today that it has received over-the-counter use market clearance from the US FDA for ActiPatch® for the adjunctive treatment of musculoskeletal pain related to (1) plantar fasciitis of the heel; and (2) osteoarthritis of the knee.

BioElectronics is an electroceutical company that develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Our innovative pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. The neuromodulation basis of PSWT presents significant opportunities for BioElectronics to develop optimized technology for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications.

Our current OTC product line includes ActiPatch® Musculoskeletal Pain Therapy, Allay® Menstrual Pain Therapy, Smart Insole™ Heel Pain Therapy, and RecoveryRx® Post-operative and Chronic Wounds Therapy. The US FDA clearance is for our flagship product the ActiPatch® Musculoskeletal Pain Therapy, developed to relieve chronic pain. ActiPatch is a drug-free, wearable nonprescription medical device that provides 720-hours (90, 8-hour treatments) of on/off therapy for $30.00 retail. Most users obtain relief with only 8 hours per day of use, so the device will generally last several months, depending on use. ActiPatch Provides:

  • Impressive Efficacy
    No harmful side effects
    A 50% Reduction in Medication Use, including opioidsExceptional Consumer Acceptance
    Demonstrated Marketability
    An adjunctive or alternative therapy to pain killers, including narcotics

About BioElectronics Corporation

BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: For more information, please visit www.bielcorp.com.

How to Order an ActiPatch®?

Visit tryactipatch.com to place your order for the ActiPatch® today.

www.tryactipatch.com 

 

CONTACT INFORMATION

 

BioElectronics Corporation
301-874-4980
info@bielcorp.com
4539 Metropolitan Court
Frederick, MD 21704

March 2017 Pictures APP Show  from Australia.



ActiPatch UK Distributors Availability Banner 11-1-15-01
 IN THE UK. WALGREEN HAS PURCHASED BOOTS 

http://www.bielcorp.com/technology/ 

 

MUST SEE  http://www.bielcorp.com/biel/wp-content/uploads/2014/01/Bioelectroceuticals-Mechanism-of-Action-Clinical-Evidence-Version-16.pdf


The Company
We are the makers of ActiPatch Therapy, RecoveryRx Devices, HealFast Therapy and the Allay family of inexpensive, disposable drug-free anti-inflammatory devices.

Our revolutionary line of pain treatment products is sold in more than 35 countries, with the simple goal of changing the way people heal.

Patents::::   
https://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Bioelectronics+Corp.%22

 

 

Retail Products 

What is ActiPatch®?
Recognized by the Wall Street Journal as one of the top medical innovations of 2009, ActiPatch® delivers its patented BioDynamic Therapy to not only relieve your pain, but to HEAL it so it doesn't come back.  Drugs and heat patches don't work to cure your pain - they simply mask it.  It always comes back.  Introducing a breakthrough in pain relief!


How does ActiPatch® work?

When cells are damaged, inflammation sets in resulting in pain, swelling, and reduced cellular energy.  ActiPatch® calms the inflammation and restores cells to their normal energy levels.  The result:  your pain and swelling diminish and your damaged cells actually begin to heal for sustained relief.  For more information visit the Technology section of our website.

Is ActiPatch® Safe?

ActiPatch® is extremely safe and comfortable to wear. The low-level current that is gently pulsed into damaged tissue is undetectable, even though the device is continuously working to help you heal. 

  http://www.allaystore.com

BIEL 
Primary Product — ActiPatch 
USPTO Patents - check 
Up to date - check 
FDA - partially OTC cleared foot and knee - check 
FDA - working with company on back clearance - check 
Trial supporting back clearance - finished - check 
FDA asked for back data pre-submission meet - check 
FDA relationship quality - fine 
Signed deals with large U.S. distributors - check, do DD 
Ongoing discussions with large U.S. retailers - check, do DD 
ActiPatch OTC cleared 50+ countries - check 
UK NHS Tariff approved for reimbursement - check 
NHS support - trial data, efficacy, safety, price 
NHS motives - public safety, efficacy, savings £100’s millions annually 
Launch - Publicly announced April 1, 2018 Post-launch ramp-up, 90 days 
NHS coverage - 100% insured patients with Rx 
Estimated price on NHS Rx launch - $ .009 to $ .02 
Estimated price on FDA OTC Back clearance - $ .04 to $ .06 
Estimated price on FDA OTC General clearance - $ .075 to $ .09 
Estimated price on U.S. retail (CVS, Walgreens) launch - $ .11 to $ .15 

Is most of this factual? You bet 
Is some of it speculative? You bet 
p.s. ActiPatch is the only miniaturized, USPTO patented, drug-free, side-effect free, safe and efficacious (FDA says so), partially FDA OTC cleared, pain management device in the world and it works well. Fact 


 


                                                                                                                                     Distributors
http://www.actipatch.com/distributors/
To order ActiPatch® online from Canada, please visit www.actipatch.ca

To order ActiPatch® online from Europe, please visit www.actipatchrelief.co.uk

 

      ~BioElectronics Corporation Website~
http://bielcorp.com/

State of Incorporation: MD
Year of Incorporation 2000

~BioElectronics Corporate Headquarters~
4539 Metropolitan Ct.
Frederick, MD 21704
Toll Free: 866-757-2284
Phone: 301-874-4890
Fax: 301-644-3937

Office Hours:
9 A.M. - 5 P.M. EST

E- mail:info@actipatch.net


$$$$$==Updates for 2017 / Products / FDA ==$$$$$ 
 

BioElectronics Corporation

 
2014 Oxford Pharmascience Group (OXP) is sponsoring BIELhttp://www.oxfordpharmascience.com/content/investors/share_price.asp 

Park Lane Hotel, Piccadilly, London 
Thursday, 6th March 2014
 

http://www.otc-bulletin.com/awards/pdfs/Nominations-Supplement-2014.pdf 
 


Approved for Olympics:                                                                                LOOK AT DR Oz
 

The UK's leading pharmacy-led health and beauty retailer

Boots UK is a member of Alliance Boots, an international pharmacy-led health and beauty group.

Our purpose is to help our customers look and feel better than they ever thought possible.  We have close to 2,500 stores from local community pharmacies to large destination health and beauty stores.  We offer fantastic products and services and you'll be cared for by expert, friendly people.   http://www.boots-uk.com/   
 

Walgreen to Spend $6.7 Billion on Alliance Boots Stake - WSJ.com  

Recent Updates



Disclaimer:
This Un-Official BIEL Message Board was created by shareholders of BIEL for Shareholders of BIEL. The intent of this board is to help shareholders and also bring discussions about BIEL to a central place.
Information above is gathered from either the internet or from other sources that could prove to be unreliable. Please do your own Due Diligence as some information may be out of date. IHub and the Moderators of this board (BIEL) will not claim nor hold any responsibility for a person(s) financial decisions. If any in-valid information is located on the BIEL board, please notify one of the moderators immediately so corrections can be made.
SureTrader
BIEL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#123229  Sticky Note Hell, I can issue a competent shareholder update Simpsonly 02/17/18 03:32:28 PM
#123050  Sticky Note Simple new device promises to treat chronic pain DewmBoom 02/15/18 07:12:58 PM
#120700  Sticky Note https://upticknewswire.com/featured-interview-vp-of-sales-keith-nalepka-of-bioel Moke31 01/22/18 08:33:45 AM
#120143  Sticky Note SEC was the one and only play left srinsocal 01/13/18 11:54:15 AM
#118106  Sticky Note Looks like...all findings...will go the SECs way...NOT-GOOD...for BIEL. stockdarockk 12/22/17 01:32:59 PM
#115902  Sticky Note Financials out. 3Q/17 Rev $458.3K. $301.3K Loss Det_Robert_Thorne 11/14/17 04:40:25 PM
#123279   Speculative factors: Simpsonly 02/19/18 12:09:05 AM
#123278   Now if only we could get seven-up to clk5192 02/18/18 11:36:48 PM
#123277   We have two tsunamis on the message board yankee55 02/18/18 09:24:23 PM
#123276   Here is a Model-Framework for Sales-of 1-Million Actipatches JustGoDeep 02/18/18 09:20:41 PM
#123275   It does not amaze me at riccikeeper 02/18/18 08:22:10 PM
#123274   A truly AWESOME job seven-up that deserves much yankee55 02/18/18 07:06:01 PM
#123273   Hey Seven---I didn't realize it was you that toohot 02/18/18 06:41:04 PM
#123272   Bravo, "Perfecto" that's what I'm talking about my Steve43 02/18/18 05:56:14 PM
#123271   Thanks to the Moderators who are posting these toohot 02/18/18 05:02:06 PM
#123270   See what you think Steve43 of Biel intro seven-up 02/18/18 04:40:47 PM
#123269   What is the bases for these numbers. WOW! Daytime_Lantern 02/18/18 04:16:13 PM
#123268   The article left out another governmental incompetent step.. pearsby09 02/18/18 03:00:08 PM
#123267   https://www.zerohedge.com/news/2018-02-18/how-kill-300000-americans-and-get-away Jimzin 02/18/18 02:17:03 PM
#123266   Run the numbers on this Stock. JustGoDeep 02/18/18 01:28:25 PM
#123265   I think the Migraine indication will be just pearsby09 02/18/18 01:07:50 PM
#123264   Wow , that's a strong opinion, can't Fencewrecker 02/18/18 12:47:24 PM
#123263   I need no one to ease my frustration, Steve43 02/18/18 12:24:30 PM
#123262   Well lets see, how about BIEL has recieved Steve43 02/18/18 12:16:46 PM
#123261   You are pinpoint accurate Simpsonly.....I can see the yankee55 02/18/18 12:10:26 PM
#123260   Most excellent point Simps! I have always looked fuja21 02/18/18 11:46:42 AM
#123259   Why not include migraine as well? bieliever 02/18/18 11:28:31 AM
#123258   Steve, I can understand where people are coming Miamifl 02/18/18 11:24:21 AM
#123257   This is SUCH a Sleeper of a Stock JustGoDeep 02/18/18 11:19:15 AM
#123256   Hey, Steve43 tell me what you want to seven-up 02/18/18 11:19:03 AM
#123255   Pssssst - here’s the real BIEL SLEEPER I Simpsonly 02/18/18 11:14:07 AM
#123254   Great Post Jimzin Thank You JustGoDeep 02/18/18 11:13:44 AM
#123253   How long will it take to correct BIEL's Steve43 02/18/18 11:10:58 AM
#123252   Gramps, if EVERYONE would pay attention to a Miamifl 02/18/18 11:01:19 AM
#123251   Yes getting change is like pulling teeth when Steve43 02/18/18 10:59:16 AM
#123250   OH yeah and add to all that NHS JustGoDeep 02/18/18 10:58:12 AM
#123249   Mundi Pharma added and selling in 9 Countries JustGoDeep 02/18/18 10:50:17 AM
#123248   Yes---great news. Perhaps we can replace the toohot 02/18/18 10:46:54 AM
#123247   Simpsonly, Does that mean that what was Miamifl 02/18/18 10:46:28 AM
#123246   Great post Simpsonly!!! Miamifl 02/18/18 10:38:18 AM
#123245   Superb post!! Thanks glta choctaw 02/18/18 10:20:41 AM
#123244   Day two of the 3 day weekend, and Steve43 02/18/18 10:19:11 AM
#123243   Stickie :) Brilliant posting ! Nice summary! Factual- check ! slopak 02/18/18 02:47:19 AM
#123242   There you go Gramps! If Mr. Stallone would art2426 02/18/18 12:03:11 AM
#123241   Nice mention of KN Interview in BIEL home srinsocal 02/17/18 11:44:16 PM
#123240   Another Confirmation of the Wearable Pain Relief Revolution srinsocal 02/17/18 11:34:42 PM
#123239   srinsocal srinsocal 02/17/18 11:19:02 PM
#123238   Huge number of Millionaires are going to be JustGoDeep 02/17/18 08:43:02 PM
#123237   Absolutely True. The Market has no idea yet JustGoDeep 02/17/18 08:39:00 PM
#123236   A truly brilliant post Simpsonly that clearly portrays yankee55 02/17/18 08:37:26 PM
#123235   Keith is going to have over 1 billion yankee55 02/17/18 08:27:10 PM
#123234   Waiting for my Hawaii vacation for team BIel Erbb 02/17/18 08:19:21 PM
#123233   I believe that we are making history. doc063 02/17/18 08:03:07 PM
#123232   We are on the right track. Good doc063 02/17/18 08:01:44 PM
#123231   D@mn straight. I can offer that there Gramps 02/17/18 05:33:30 PM
#123230   At least bielcorp is listening to shareholders. Put Erbb 02/17/18 03:34:02 PM
PostSubject